Agilon Health, Inc. (AGL) Stock Score, Valuation & Financial Research
Agilon Health, Inc. is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 26/100.
Quick answer for AGL
Agilon Health, Inc. currently has a Wall Street Score of 26/100. The stored market price is $92.38. Its financial score is 25/100. Its valuation score is 0/100. The latest WSS change is -0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What Agilon Health, Inc. does
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.
AGL financial snapshot
- Wall Street Score:
- 26/100
- Current price:
- $92.38
- Market capitalization:
- $1.54B
- Revenue:
- $5.92B
- Net income:
- $-251.2M
- Free cash flow:
- $-119.0M
- Cash:
- $107.2M
- Total debt:
- $33.4M
- EPS:
- -15.38
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 34/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $-119.0M, showing cash burn in the current stored period.
- The balance sheet shows $107.2M of cash versus $33.4M of total debt, leaving more cash than debt.
- The latest Wall Street Score change is -0.1 points: AGL decreased 0.1 points because some fundamentals weakened.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-08.
How to research AGL
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.